Unintended HIV-1 Infection During Analytical Therapy Interruption

被引：29
|
作者：
Ugarte, Ainoa [1 ]
Romero, Yolanda [1 ]
Tricas, Amparo [1 ]
Casado, Concepcion [2 ]
Lopez-Galindez, Cecilio [2 ]
Garcia, Felipe [1 ,3 ]
Leal, Lorna [1 ,3 ]
机构：
[1] Univ Barcelona, Hosp Clin Barcelona, Infect Dis HIV Unit, Barcelona, Spain
[2] Inst Salud Carlos III, Mol Virol Unit, Natl Ctr Inst Salud Carlos III, Madrid, Spain
[3] Inst Invest Biomed August Pi Sunyer IDIBAP, AIDS Res Grp, HIVACAT HIV Vaccine Dev Program, Barcelona, Spain
来源：
JOURNAL OF INFECTIOUS DISEASES | 2020年 / 221卷 / 10期
关键词：
D O I：
10.1093/infdis/jiz611
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1740 / 1742
页数：3
相关论文
共 50 条
  • [31] New therapy to revert dysfunctional antibody responses during HIV-1 infection
    Chiodi, Francesca
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (11): : 3810 - 3813
  • [32] Educational attainment and response to HAART during initial therapy for HIV-1 infection
    Marc, Linda G.
    Testa, Marcia A.
    Walker, Alexander M.
    Robbins, Gregroy K.
    Shafer, Robert W.
    Anderson, Norman B.
    Berkman, Lisa F.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2007, 63 (02) : 207 - 216
  • [33] ZIDOVUDINE THERAPY OF HIV-1 INFECTION DURING PREGNANCY - ASSESSMENT OF THE EFFECT ON THE NEWBORNS
    FERRAZIN, A
    DEMARIA, A
    GOTTA, C
    MAZZARELLO, G
    CANESSA, A
    CIRAVEGNA, B
    CIRILLO, C
    MELICA, F
    TERRAGNA, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (04): : 376 - 379
  • [34] Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection
    Chamberland, A.
    Sylla, M.
    Boulassel, M. R.
    Baril, J-G
    Cote, P.
    Thomas, R.
    Trottier, B.
    Rouleau, D.
    Routy, J-P
    Tremblay, C.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (03) : 146 - 150
  • [35] Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence
    Pomerantz, RJ
    AIDS, 2001, 15 (10) : 1201 - 1211
  • [36] The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir
    Kempf, DJ
    Rode, RA
    Xu, Y
    Sun, E
    Heath-Chiozzi, ME
    Valdes, J
    Japour, AJ
    Danner, S
    Boucher, C
    Molla, A
    Leonard, JM
    AIDS, 1998, 12 (05) : F9 - F14
  • [37] High levels of cervical HIV-1 RNA during early HIV-1 infection
    Lavreys, Ludo
    Baeten, Jared M.
    Panteleeff, Dana D.
    Richardson, Barbra A.
    McClelland, R. Scott
    Chohan, Varsha
    Mandaliya, Kishorchandra
    Ndinya-Achola, Jeckoniah O.
    Overbaugh, Julie
    AIDS, 2006, 20 (18) : 2389 - 2390
  • [38] Clonal analysis of HIV-1 variants in proviral DNA during treatment interruption in patients with multiple therapy failures
    Boucher, S
    Recordon-Pinson, P
    Neau, D
    Ragnaud, JM
    Faure, M
    Fleury, H
    Masquelier, B
    ANTIVIRAL THERAPY, 2003, 8 (03) : U71 - U71
  • [39] Early antiretroviral therapy reduces HIV-1 DNA following perinatal HIV-1 infection
    Foster, C.
    Kaye, S.
    Fidler, S.
    Pace, M.
    Jones, M.
    Hopkins, E.
    Robinson, N.
    Frater, J.
    HIV MEDICINE, 2015, 16 : 6 - 6
  • [40] Investigation of HIV-1 evolution following early therapy in patients with primary HIV-1 infection
    Huckett, L
    Devereux, H
    Loveday, C
    Kinloch, S
    Janossy, G
    AIDS, 1998, 12 : S22 - S22
12345